Vienna (ots/PRNewswire) - Elan Corporation, plc (NYSE: ELN) and Wyeth (NYSE: WYE) presented information this week at the Alzheimer Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) from seven posters and one podium presentation about the growing burden of care and costs associated ...
Collegeville, Pennsylvania (ots/PRNewswire) - - Chile Grants First Approval of Prevenar 13 for the Prevention of Pneumococcal Disease in Infants and Children- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the Chilean Ministry of Health, MINSAL (Ministerio de Salud), has become the first government agency to approve Prevenar 13* Valent, (Pneumococcal Conjugate Vaccine 13 Valent ...
Maidenhead, England (ots/PRNewswire) - - Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide Israel has initiated a national immunisation programme (NIP) against pneumococcal disease with Wyeth Pharmaceuticals' vaccine Prevenar(tm) ...
London (ots/PRNewswire) - Perenco Ecuador Limited ("Perenco Ecuador") and its consortium partner, Burlington Resources Oriente Ltd. ("Burlington"), today announced that suspension of their participation contracts with Ecuador is imminent unless the Government of Ecuador complies with orders of two ...
Vienna (ots/PRNewswire) - - Attitudinal and Behavioural Barriers(1) - Combined with Inability to Recognize Disease Symptoms(1) - Contribute to Delay in Diagnosis and Treatment A new study presented today at a major International medical meeting reveals that approximately two-thirds of physicians in ...
San Jose, California (ots/PRNewswire) - - SRAM-based key storage ensures keys are permanently destroyed if IC is removed from battery Atmel(R) Corporation (Nasdaq: ATML) announced today its AT88SA100S (http://www.atmel.com/products/cryptoauthentication/default.asp ) ultra low-cost, cryptographic battery ...
London (ots/PRNewswire) - Perenco Ecuador Limited ("Perenco Ecuador") today called on the Government of Ecuador to cease efforts to sell oil seized from Blocks 7 and 21 in defiance of orders by international arbitration tribunals, and instead to seek a negotiated solution to the dispute concerning the applicability of Law 42 to Blocks 7 and 21. Perenco ...
San Jose, California (ots/PRNewswire) - Atmel(R) Corporation (Nasdaq: ATML) announced today that the company has received LIN2.1 certification for its LIN transceiver ATA6662 and LIN System Basis Chip ATA6624. The LIN2.1 physical layer test, which is the basis for LIN certification as defined by the ...
Leiden, The Netherlands (ots/PRNewswire) - Three new small and medium sized enterprises (SMEs) - Syncom, Synvolux Therapeutics and InteRNA Technologies - have joined public-private partnership TI Pharma by participating in two new projects. These projects, focusing on cancer and inflammatory diseases, have a total budget of nearly 6 million euros. The new ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical ...
London (ots/PRNewswire) - Perenco Ecuador Limited ("Perenco Ecuador") today announced that it is prepared to take legal action against any company that purchases or transports crude oil the Ecuadorian Government has unlawfully seized. Perenco Ecuador is the Operator of Blocks 7 and 21 in Ecuador. ...
Cambridge, England (ots/PRNewswire) - AVEVA (LSE:AVV) announced today that it has made further enhancements to its AVEVA Marine portfolio. With a main focus on interoperability, this new release of the AVEVA Marine portfolio now offers AVEVA's marine customers extended possibilities for data exchange between various sources. AVEVA Marine users will now be able to integrate P&IDs and schematic diagrams coming ...
Paris (ots/PRNewswire) - - Multaq(R) Approved to Reduce the Risk of Cardiovascular Hospitalization in Patients With Atrial Fibrillation or Atrial Flutter - U.S Commercial Launch Planned for the Summer of 2009 Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) ...
San Francisco (ots/PRNewswire) - Visa Inc. (NYSE: V) announced that Visa International, its wholly-owned subsidiary, sold 136,478,372 shares of Companhia Brasileira de Meios de Pagamento ("VisaNet do Brasil"), in connection with VisaNet do Brasil's June IPO. Visa's proceeds from the sale, net of underwriter discounts and fees, are approximately US$1 ...
Amsterdam, The Netherlands (ots/PRNewswire) - - "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment" New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in ...
Basel (ots/PRNewswire) - - For non-US, non-UK and non-Austrian Media Patients with advanced (metastatic) breast cancer will be able to benefit from treatment with Avastin (bevacizumab) as a result of a new broader label recommendation in Europe, Roche announced today. The positive opinion issued by the ...
Hatfield, England (ots/PRNewswire) - - Leading Research-Based Pharmaceutical Company Creates New Manufacturing and Research Jobs in UK Eisai, one of the world's leading pharmaceutical companies, today officially opened its new 'European Knowledge Centre' (the EKC) in Hatfield, Hertfordshire. Committed to developing new medicines for patients ...
Malmo, Sweden (ots/PRNewswire) - In the news release, "ABS Wins Order for Compressors for Treatment Plant in Switzerland" issued on 26 Jun 2009 06:45 GMT, by ABS Group over PR Newswire, we are advised by a representative of the company that the third paragraph containing the company information was missing, as incorrectly transmitted by PR Newswire. Complete, corrected release follows: ABS will be supplying compressors for one of the biggest treatment plants in ...
Geneva, and Redwood City, California (ots/PRNewswire) - - Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - Genomic Health, Inc. (Nasdaq: GHDX) today reported that the St. Gallen International Consensus ...
Sydney (ots/PRNewswire) - - Rod Beckstrom is Global Entrepreneur, Analyst and Author Internet founders and leaders are joining industry executives and government officials in praising the selection of Rod Beckstrom as the new Chief Executive Officer and President of the Internet Corporation for Assigned Names and Numbers (ICANN). (Photo: http://www.newscom.com/cgi-bin/prnh/20090626/DC38669 ) "Rod ...
Ingelheim, Germany (ots/PRNewswire) - - For non-U.S. Healthcare Media Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for ...
New York (ots/PRNewswire) - Michael Jackson, one of the most widely beloved entertainers and profoundly influential artists of all-time, leaves an indelible imprint on popular music and culture. Commenting on his passing, Sir Howard Stringer, Chairman, CEO and President, Sony Corporation, said: "Michael Jackson was a brilliant troubadour for his generation, a genius whose music reflected the passion and ...
Bristol-Myers Squibb and AstraZeneca
Paris and London (ots/PRNewswire) - Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (LSE: AZN) today announced that their marketing authorisation application for ONGLYZA(TM) (saxagliptin) received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of type 2 diabetes in adults as add-on therapy with metformin, ...
Paris and Redmond, Washington (ots/PRNewswire) - - Companies Pursue More Engaging Digital Content, Increased Marketing Performance and Sharply-Defined Audiences Microsoft and Publicis Groupe today announced a broad agreement to closely cooperate on three core objectives enabled by the emergence of the digital media world. Focusing on Content, Performance ...
Kazan, Russia (ots/PRNewswire) - Today MetaQuotes Software Corp. released the trial version of the groupware system TeamWox. (http://www.teamwox.com/en/demo/download/) TeamWox belongs to the class of software that allows you to organize the efficient teamwork within a company. Its revolutionary innovations ...
Abbott Park, Illinois (ots/PRNewswire) - - Broad Size Matrix of XIENCE PRIME to be Launched in Europe in the Third Quarter Abbott announced today that it has received CE Mark (Conformite Europeenne) for its next-generation XIENCE PRIME(TM) Everolimus Eluting Coronary Stent System for the treatment of ...
Huntington Beach, California and Amsterdam (ots/PRNewswire) - - International Expert Panel Recommends Use of Multigene Profiling Assays and Finds Intermediate Scores Lack Clinical Utility Agendia, a world leader in molecular cancer diagnostics, today announced the inclusion of its breast cancer recurrence ...
Maidenhead, England (ots/PRNewswire) - - My Day for RA Launches Across Europe Today: A Novel 'Goal-Centred' Patient Programme Recognising that rheumatoid arthritis (RA) can cause deformity, disability and loss of independence without effective management - My Day for RA, a new educational programme, ...
San Jose, California (ots/PRNewswire) - - picoPower AVR32 AT32UC3L Microcontroller offers less than 0.48 mW/MHz Active and below 100 nA Sleep Mode, and has Embedded Capacitive Touch Peripheral and Event System that Eliminates Interrupt Handling and Guarantees Deterministic Response Time Atmel(R) ...
Astellas Pharma Europe Limited
San Mateo, California and Staines, England (ots/PRNewswire) - - Conference Call Today at 9:00am ET - Covers Europe, Middle East and Africa - Includes Licensing Option and Development Funding for NGX-1998 NeurogesX, Inc. (NASDAQ: NGSX) and Astellas Pharma Europe Ltd., (Astellas), the European subsidiary of Tokyo based Astellas Pharma Inc. announced ...